1. Home
  2. FSP vs NKTR Comparison

FSP vs NKTR Comparison

Compare FSP & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSP
  • NKTR
  • Stock Information
  • Founded
  • FSP 1981
  • NKTR 1990
  • Country
  • FSP United States
  • NKTR United States
  • Employees
  • FSP N/A
  • NKTR N/A
  • Industry
  • FSP Real Estate Investment Trusts
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSP Real Estate
  • NKTR Health Care
  • Exchange
  • FSP Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • FSP 159.5M
  • NKTR 160.4M
  • IPO Year
  • FSP N/A
  • NKTR 1994
  • Fundamental
  • Price
  • FSP $1.52
  • NKTR $0.64
  • Analyst Decision
  • FSP
  • NKTR Strong Buy
  • Analyst Count
  • FSP 0
  • NKTR 6
  • Target Price
  • FSP N/A
  • NKTR $4.92
  • AVG Volume (30 Days)
  • FSP 424.6K
  • NKTR 2.8M
  • Earning Date
  • FSP 04-29-2025
  • NKTR 05-08-2025
  • Dividend Yield
  • FSP 2.61%
  • NKTR N/A
  • EPS Growth
  • FSP N/A
  • NKTR N/A
  • EPS
  • FSP N/A
  • NKTR N/A
  • Revenue
  • FSP $120,112,000.00
  • NKTR $98,427,000.00
  • Revenue This Year
  • FSP $4.36
  • NKTR N/A
  • Revenue Next Year
  • FSP $0.81
  • NKTR N/A
  • P/E Ratio
  • FSP N/A
  • NKTR N/A
  • Revenue Growth
  • FSP N/A
  • NKTR 9.21
  • 52 Week Low
  • FSP $1.36
  • NKTR $0.43
  • 52 Week High
  • FSP $2.21
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • FSP 32.73
  • NKTR 45.85
  • Support Level
  • FSP $1.36
  • NKTR $0.43
  • Resistance Level
  • FSP $1.84
  • NKTR $0.68
  • Average True Range (ATR)
  • FSP 0.09
  • NKTR 0.08
  • MACD
  • FSP -0.02
  • NKTR 0.01
  • Stochastic Oscillator
  • FSP 33.33
  • NKTR 72.41

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: